BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 9361293)

  • 1. Zinc metabolism in the brain: relevance to human neurodegenerative disorders.
    Cuajungco MP; Lees GJ
    Neurobiol Dis; 1997; 4(3-4):137-69. PubMed ID: 9361293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain, aging and neurodegeneration: role of zinc ion availability.
    Mocchegiani E; Bertoni-Freddari C; Marcellini F; Malavolta M
    Prog Neurobiol; 2005 Apr; 75(6):367-90. PubMed ID: 15927345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes.
    Calabrese V; Boyd-Kimball D; Scapagnini G; Butterfield DA
    In Vivo; 2004; 18(3):245-67. PubMed ID: 15341181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuronal cell death in neurodegenerative disorders and oxidative stress].
    Shimohama S; Sawada H; Kihara T; Urushitani M
    Rinsho Shinkeigaku; 1999 Jan; 39(1):4-6. PubMed ID: 10377784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
    J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role for oxidative stress in neurodegenerative diseases].
    Shibata N; Kobayashi M
    Brain Nerve; 2008 Feb; 60(2):157-70. PubMed ID: 18306664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects for antiapoptotic drug therapy of neurodegenerative diseases.
    Waldmeier PC
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):303-21. PubMed ID: 12657369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Submolecular adventures of brain tyrosine: what are we searching for now?
    Kochman A; Kośka C; Metodiewa D
    Amino Acids; 2002; 23(1-3):95-101. PubMed ID: 12373523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc: the brain's dark horse.
    Bitanihirwe BK; Cunningham MG
    Synapse; 2009 Nov; 63(11):1029-49. PubMed ID: 19623531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional and translational regulation of BACE1 expression--implications for Alzheimer's disease.
    Rossner S; Sastre M; Bourne K; Lichtenthaler SF
    Prog Neurobiol; 2006 Jun; 79(2):95-111. PubMed ID: 16904810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of the zinc transporter ZnT-1 in comparison with chelatable zinc in the mouse brain.
    Sekler I; Moran A; Hershfinkel M; Dori A; Margulis A; Birenzweig N; Nitzan Y; Silverman WF
    J Comp Neurol; 2002 Jun; 447(3):201-9. PubMed ID: 11984815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synaptic zinc in the central nervous system].
    López-García C; Molowny A; Ponsoda X; Nácher J; Sancho-Bielsa F
    Rev Neurol; 2001 Aug 16-31; 33(4):341-7. PubMed ID: 11588729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician Education: Apoptosis.
    Kataoka S; Tsuruo T
    Oncologist; 1996; 1(6):399-401. PubMed ID: 10388021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Free radicals and antioxidants: physiology, human pathology and therapeutic aspects (part II)].
    Sahnoun Z; Jamoussi K; Zeghal KM
    Therapie; 1998; 53(4):315-39. PubMed ID: 9806002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
    Abdul HM; Calabrese V; Calvani M; Butterfield DA
    J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cadmium on structure and enzymatic activity of Cu,Zn-SOD and oxidative status in neural cells.
    Huang YH; Shih CM; Huang CJ; Lin CM; Chou CM; Tsai ML; Liu TP; Chiu JF; Chen CT
    J Cell Biochem; 2006 Jun; 98(3):577-89. PubMed ID: 16440303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease pathogenesis and therapeutic interventions.
    Parihar MS; Hemnani T
    J Clin Neurosci; 2004 Jun; 11(5):456-67. PubMed ID: 15177383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation.
    Koistinaho M; Kettunen MI; Goldsteins G; Keinänen R; Salminen A; Ort M; Bures J; Liu D; Kauppinen RA; Higgins LS; Koistinaho J
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1610-5. PubMed ID: 11818564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.